News from cellular biomedicine group A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jun 18, 2019, 07:30 ET ­Cellular Biomedicine Group Executives to Present at CAR-TCR Summit Asia

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Jun 17, 2019, 07:00 ET Cellular Biomedicine Group Announces First Patient Dosing in Phase I Clinical Trial of Anti-CD20 CAR-T for Lymphoma in China

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


May 29, 2019, 08:45 ET Cellular Biomedicine Group to Present at International Society for Cell and Gene Therapy Annual Meeting

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies...


May 20, 2019, 08:00 ET Cellular Biomedicine Group to Present at B. Riley FBR Annual Investor Conference

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies...


Apr 30, 2019, 17:24 ET Cellular Biomedicine Group Reports First Quarter 2019 Results and Highlights Operational Progress

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of...


Apr 29, 2019, 09:00 ET Cellular Biomedicine Group Announces Results of 2019 Annual Meeting of Stockholders

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies...


Apr 25, 2019, 09:00 ET Cellular Biomedicine Group to Report First Quarter 2019 Results and Host Conference Call on May 1, 2019

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Apr 23, 2019, 08:30 ET Cellular Biomedicine Group Upgraded to NASDAQ Global Select Market

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies...


Apr 15, 2019, 09:20 ET Cellular Biomedicine Group to Participate in Asia Pharma R&D Leaders Summit 2019

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies...


Apr 05, 2019, 09:00 ET Cellular Biomedicine Group to Present at Annual BioCentury Future Leaders in the Biotech Industry Conference

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies...


Mar 28, 2019, 09:00 ET Cellular Biomedicine Group (CBMG) Announces Annual Meeting of Stockholders

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies ...


Mar 21, 2019, 08:58 ET Cellular Biomedicine Group Announces Pricing of Public Offering of Common Stock

Cellular Biomedicine Group, Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies...


Mar 20, 2019, 16:01 ET Cellular Biomedicine Group Announces Proposed Follow-on Offering of Common Stock

Cellular Biomedicine Group Inc. (Nasdaq: CBMG) (CBMG or the Company), a biopharmaceutical company engaged in the drug development of immunotherapies...


Feb 27, 2019, 18:53 ET Cellular Biomedicine Group to Present at 8th Annual SVB Leerink Global Healthcare Conference

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies for ...


Feb 19, 2019, 19:58 ET Cellular Biomedicine Group Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Operational Progress

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) (CBMG or the Company), a biopharmaceutical firm engaged in the drug development of immunotherapies...


Jan 17, 2019, 06:00 ET Cellular Biomedicine Group's AlloJoin® Therapy for Knee Osteoarthritis (KOA) Becomes the First Stem Cell Drug Application Approved in China for Phase II Clinical Trials

Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the development of immunotherapies for ...


Jan 08, 2019, 19:30 ET Cellular Biomedicine Group Initiates Patient Recruitment for Clinical Trial in B Cell Maturation Antigen (Anti-BCMA) Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Targeting Multiple Myeloma (MM)

Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the development of immunotherapies for...


Dec 13, 2013, 03:33 ET Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I Clinical Trial for Liver Cancer

Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...


Nov 09, 2013, 05:55 ET Cellular Biomedicine Group Announces Adjournment of Its Annual Shareholder Meeting

Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today convened the annual meeting of its shareholders. Because a quorum was not achieved by shares...


Nov 07, 2013, 02:45 ET Cellular Biomedicine Group Announces November 07, 2013 as Voting Deadline for Its Annual Shareholder Meeting

Cellular Biomedicine Group, Inc. (OTCQB: CBMG) today reminded all its shareholders that the Board of the Company has set November 08, 2013 as the...


Nov 05, 2013, 11:36 ET Cellular Biomedicine Group Receives Approval for Phase IIb Clinical Trial of ReJoin™ for Treatment of Knee Osteoarthritis (KOA)

Cellular Biomedicine Group, Inc. (OTCQB: CBMG), a biomedicine firm engaged in the development of new treatments for degenerative and cancerous...


Nov 01, 2013, 10:01 ET Cellular Biomedicine Group Announces Completion of Patient Treatment for Phase I/IIa Clinical Trial for Treatment of Knee Osteoarthritis (KOA)

Cellular Biomedicine Group, Inc. (OTCQB: CBMG) is pleased to announce that it has treated the final patient of its Phase I/IIa clinical trial for...


Oct 30, 2013, 09:01 ET Cellular Biomedicine Group Announces New Product Approved for Market in China and New Exclusive License

Today Cellular Biomedicine Group (OTCQB:CBMG) announced that their A-Stromal™ adipose stromal cell purification kit is ready to launch on the market...


Oct 25, 2013, 10:08 ET Cellular Biomedicine Group calls for General Annual Shareholder Meeting on November 08, 2013

Cellular Biomedicine Group, Inc. (OTCQB:CBMG) today announced that the Board of the Company has set November 08, 2013 as the date for the Company's...


Oct 01, 2013, 07:50 ET Cellular Biomedicine Group Announces Appointment of New CEO

Cellular Biomedicine Group, Inc. (OTCQB: CBMG) announced today that it has promoted Dr. Wei (William) Cao to serve as its Chief Executive Officer. Dr....